Report Scope & Overview:
The global Point of Care Diagnostics (POCD) market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
The Point of Care Diagnostics (POCD) Market is growing rapidly due to the increasing demand for rapid diagnostic tests, advancements in technology, and the shift towards decentralized healthcare. POCD refers to medical diagnostic testing performed at or near the site of patient care, providing immediate results and enabling prompt clinical decisions. These diagnostics are used in a variety of settings, including hospitals, clinics, physician offices, and homecare, offering convenience and efficiency in disease management.
Key Segments within the Point of Care Diagnostics Market:
Types of POCD:
- Blood Glucose Testing: Devices and kits for monitoring blood glucose levels, particularly essential for diabetes management.
- Infectious Disease Testing: Tests for diseases such as HIV, influenza, COVID-19, and other infections.
- Cardiometabolic Monitoring: Tests for cholesterol, triglycerides, and cardiac markers to monitor heart health.
- Pregnancy and Fertility Testing: Kits for detecting pregnancy and ovulation.
- Coagulation Testing: Devices that monitor blood clotting time, crucial for patients on anticoagulant therapy.
- Hematology Testing: Tests for blood cell counts and hemoglobin levels.
- Urinalysis: Tests to analyze urine samples for various conditions.
- Cancer Markers: Tests that detect biomarkers associated with different types of cancer.
- Cholesterol Testing: Devices and kits to measure cholesterol levels.
End Users:
- Hospitals and Clinics: Use POCD for rapid diagnosis and immediate treatment decisions.
- Homecare Settings: Increasingly used by patients for self-monitoring and managing chronic conditions.
- Ambulatory Care Settings: Utilized in outpatient settings for quick diagnostics.
- Diagnostic Laboratories: Employed for initial screenings and confirmatory tests.
- Research Institutes: Used for studies and development of new diagnostic tests.
Applications:
- Infectious Diseases: Rapid detection and management of infectious diseases.
- Chronic Disease Management: Monitoring and managing chronic diseases like diabetes and cardiovascular conditions.
- Emergency Medicine: Quick diagnostics in emergency situations to facilitate immediate care.
- Pediatrics: Use in children for quick and non-invasive diagnostic tests.
- Geriatrics: Use in elderly patients for managing multiple chronic conditions.
Market Drivers and Trends:
- Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases like diabetes, cardiovascular diseases, and infectious diseases drives the demand for POCD.
- Technological Advancements: Innovations in diagnostic technology, including the development of portable, user-friendly, and accurate POCD devices, enhance market growth.
- Rising Demand for Home-based Testing: The growing trend towards home healthcare and self-monitoring boosts the demand for POCD devices.
- COVID-19 Pandemic: The pandemic significantly increased the demand for rapid diagnostic tests, highlighting the importance of POCD in managing infectious diseases.
- Decentralized Healthcare: The shift towards decentralized healthcare and personalized medicine promotes the adoption of POCD.
Challenges:
- High Cost of POCD Devices: The expense of advanced POCD devices can be a barrier, particularly in low- and middle-income countries.
- Regulatory Hurdles: Stringent regulatory requirements for approval and quality control can delay market entry and increase development costs.
- Accuracy and Reliability Issues: Ensuring consistent accuracy and reliability of POCD results is crucial for effective disease management.
- Lack of Awareness and Training: Limited awareness and training on the use of POCD devices can hinder their adoption.
Future Outlook: The POCD market is expected to continue its robust growth trajectory, driven by the ongoing need for rapid, accurate, and accessible diagnostic solutions. Future advancements are likely to focus on enhancing the accuracy, portability, and connectivity of POCD devices, integrating them with digital health platforms for real-time data sharing and remote monitoring. The incorporation of artificial intelligence (AI) and machine learning (ML) for data analysis and predictive diagnostics is also anticipated to revolutionize the market. Expanding access to POCD in emerging markets, addressing cost-related challenges, and ensuring regulatory compliance will be crucial for sustained market growth. Collaboration between healthcare providers, technology developers, and policymakers will be essential to leverage these advancements and improve global health outcomes.
The Point of Care Diagnostics (POCD) Market is growing rapidly due to the increasing demand for rapid diagnostic tests, advancements in technology, and the shift towards decentralized healthcare. POCD refers to medical diagnostic testing performed at or near the site of patient care, providing immediate results and enabling prompt clinical decisions. These diagnostics are used in a variety of settings, including hospitals, clinics, physician offices, and homecare, offering convenience and efficiency in disease management.
Market Drivers and Trends:
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases like diabetes, cardiovascular diseases, and infectious diseases drives the demand for POCD.
Technological Advancements: Innovations in diagnostic technology, including the development of portable, user-friendly, and accurate POCD devices, enhance market growth.
Rising Demand for Home-based Testing: The growing trend towards home healthcare and self-monitoring boosts the demand for POCD devices.
COVID-19 Pandemic: The pandemic significantly increased the demand for rapid diagnostic tests, highlighting the importance of POCD in managing infectious diseases.
Decentralized Healthcare: The shift towards decentralized healthcare and personalized medicine promotes the adoption of POCD.
Challenges:
High Cost of POCD Devices: The expense of advanced POCD devices can be a barrier, particularly in low- and middle-income countries.
Regulatory Hurdles: Stringent regulatory requirements for approval and quality control can delay market entry and increase development costs.
Accuracy and Reliability Issues: Ensuring consistent accuracy and reliability of POCD results is crucial for effective disease management.
Lack of Awareness and Training: Limited awareness and training on the use of POCD devices can hinder their adoption.
Future Outlook:
The POCD market is expected to continue its robust growth trajectory, driven by the ongoing need for rapid, accurate, and accessible diagnostic solutions. Future advancements are likely to focus on enhancing the accuracy, portability, and connectivity of POCD devices, integrating them with digital health platforms for real-time data sharing and remote monitoring. The incorporation of artificial intelligence (AI) and machine learning (ML) for data analysis and predictive diagnostics is also anticipated to revolutionize the market. Expanding access to POCD in emerging markets, addressing cost-related challenges, and ensuring regulatory compliance will be crucial for sustained market growth. Collaboration between healthcare providers, technology developers, and policymakers will be essential to leverage these advancements and improve global health outcomes.
Market Segmentations:
Global Point of Care Diagnostics (POCD) Market: By Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Global Point of Care Diagnostics (POCD) Market: By Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Global Point of Care Diagnostics (POCD) Market: By Application
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
| Report Attribute/Metric | Details |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Historical Data | 2019-2023 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | Blood Glucose Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Pregnancy and Fertility Testing Blood Gas/Electrolytes Testing Tumor Markers Testing Urinalysis Testing Cholesterol Testing Others |
| By Application | Clinics Hospitals Assisted Living Healthcare Facilities Laboratory |
| Key Companies Profiled | Alere Roche Abbott Laboratories Johnson & Johnson Siemens Healthcare Danaher QIAGEN Bayer Healthcare Beckman Coulter Nipro Diagnostics Bio-Rad Laboratories Nova Biomedical BioMerieux Quidel Helena Laboratories OraSure Technologies Accriva Abaxis Chembio Diagnostics Trinity Biotech Instrumentation Laboratory Sekisui Diagnostics |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Global Point of Care Diagnostics (POCD) Market: Regional Analysis
The regional analysis of the global Point of Care Diagnostics (POCD) market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Point of Care Diagnostics (POCD) market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Point of Care Diagnostics (POCD) in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Point of Care Diagnostics (POCD) in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Point of Care Diagnostics (POCD) in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Point of Care Diagnostics (POCD) in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
Reasons to Purchase Point of Care Diagnostics (POCD) Market Report:
Firstly, Point of Care Diagnostics (POCD) market report provides invaluable insights into market dynamics, encompassing factors like industry trends, consumer behavior, and competitive analysis. By understanding these dynamics, businesses can identify opportunities for growth and anticipate potential threats, empowering them to make informed decisions that align with their strategic objectives.
Secondly, the quality and reliability of market research reports are paramount. Trusted sources and rigorous methodologies ensure the accuracy and credibility of the data presented. This reliability instills confidence in businesses, enabling them to base their strategies on solid foundations and navigate uncertainties with greater certainty.
Thirdly, Point of Care Diagnostics (POCD) market research reports offer a cost-effective solution for accessing comprehensive market intelligence. Rather than investing time and resources in conducting extensive research internally, businesses can rely on these reports to deliver actionable insights in a fraction of the time. This efficiency translates into cost savings and allows organizations to allocate resources more strategically.
Moreover, Point of Care Diagnostics (POCD) market research reports provide deep insights into consumer behavior, helping businesses understand preferences, trends, and purchasing patterns. By leveraging this information, companies can tailor their products and services to meet evolving customer needs, fostering customer satisfaction and loyalty.
Lastly, Point of Care Diagnostics (POCD) market research reports aid in strategic planning by facilitating informed decision-making. From identifying growth opportunities to mitigating risks, these reports equip businesses with the knowledge needed to develop effective strategies that drive sustainable growth and maintain a competitive edge in the market.
Objectives of Point of Care Diagnostics (POCD) Market Study:
Understanding Market Dynamics: Point of Care Diagnostics (POCD) Market research reports aim to provide a comprehensive understanding of the market environment, including industry trends, consumer behavior, and competitive landscape. By analyzing market dynamics, businesses can make informed decisions and adapt their strategies to meet evolving market demands.
Identifying Growth Opportunities: Another objective of Point of Care Diagnostics (POCD) market research reports is to identify potential growth opportunities within the market. By analyzing market trends and consumer preferences, businesses can pinpoint areas of unmet needs or underserved segments, allowing them to develop targeted strategies to capitalize on these opportunities.
Assessing Competitor Strategies: Point of Care Diagnostics (POCD) Market reports also help businesses assess competitor strategies and market positioning. By analyzing competitor performance, product offerings, and marketing tactics, companies can identify competitive strengths and weaknesses, enabling them to refine their own strategies and gain a competitive advantage.
Mitigating Risks: Understanding market risks is another key objective of Point of Care Diagnostics (POCD) market reports. By conducting thorough market analysis, businesses can identify potential threats such as changing consumer preferences, regulatory changes, or new market entrants. This allows them to develop risk mitigation strategies to safeguard their business operations.
Informing Decision Making: Ultimately, the primary objective of Point of Care Diagnostics (POCD) market reports is to provide actionable insights that inform strategic decision-making. By providing data-driven insights and recommendations, market research reports empower businesses to make informed decisions regarding product development, marketing strategies, and resource allocation, ultimately driving business growth and profitability.
Frequently Asked Questions
Growth is driven by increasing demand for rapid diagnostic tests, rising prevalence of chronic and infectious diseases, advancements in POCD technology, and the need for decentralized healthcare.
North America leads the market due to advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and supportive regulatory policies. Europe and Asia-Pacific also show significant growth potential due to increasing healthcare expenditures and rising prevalence of diseases.
Key challenges include regulatory hurdles, variability in test accuracy and reliability, high costs of advanced POCD devices, and the need for user training and education.
Major players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation (Cepheid), and Becton, Dickinson and Company (BD).
Emerging trends include the development of portable and handheld POCD devices, integration of POCD with digital health platforms and electronic medical records (EMRs), increasing use of biosensors and microfluidics, and growing focus on personalized and home-based diagnostics.
TABLE OF CONTENT
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type:
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Growth by Application:
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective
2.2 Point of Care Diagnostics (POCD) Growth Trends by Region
2.2.1 Global Point of Care Diagnostics (POCD) Market Size by Region:
2.2.2 Point of Care Diagnostics (POCD) Historic Market Size by Region
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Region
2.3 Point of Care Diagnostics (POCD) Market Dynamics
2.3.1 Point of Care Diagnostics (POCD) Industry Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2023
3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size
6.2 North America Point of Care Diagnostics (POCD) Market Growth Rate by Country:
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size
7.2 Europe Point of Care Diagnostics (POCD) Market Growth Rate by Country:
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Growth Rate by Region:
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size
9.2 Latin America Point of Care Diagnostics (POCD) Market Growth Rate by Country:
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Country
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Growth Rate by Country:
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Detail
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Detail
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Detail
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Detail
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Detail
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Detail
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Detail
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business
11.18.5 Abaxis Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
11.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business
11.19.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Detail
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Detail
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Detail
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Delivery Microcatheter Market
Global Delivery Microcatheter Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Elastography System Market
Global Elastography System Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Orthopedic Robots Market
Global Orthopedic Robots Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Allergy Non-pharmacologic Therapy Market
Global Allergy Non-pharmacologic Therapy Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Dental Anaesthetic Needles Market
Global Dental Anaesthetic Needles Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast